Temporal trends in care and outcomes of patients receiving fibrinolytic therapy compared to primary percutaneous coronary intervention: Insights from the Get With the Guidelines Coronary Artery Disease (GWTG-CAD) registry

Journal of the American Heart Association

Volumn 5, Issue 10, 2016, Pages

  Hira, Ravi S ^a   Bhatt, Deepak L ^b   Fonarow, Gregg C ^c   Heidenreich, Paul A ^d,e   Ju, Christine ^f   Virani, Salim S ^g,h   Bozkurt, Biykem ^g,h   Petersen, Laura A ^g,h   Hernandez, Adrian F ^f   Schwamm, Lee H ^b,i   Eapen, Zubin J ^f   Albert, Michelle A ^j   Liang, Li ^f   Matsouaka, Roland A ^f   Peterson, Eric D ^f   Jneid, Hani ^g,h  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^g MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Fibrinolysis; Myocardial infarction; Outcome and process assessment; Primary percutaneous coronary intervention

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL OUTCOME; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE REGISTRY; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HOSPITAL MORTALITY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PERFORMANCE MEASUREMENT SYSTEM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY DELAY; TIME TO TREATMENT; TREND STUDY; AGED; COHORT ANALYSIS; FACTUAL DATABASE; REGISTER; TREATMENT OUTCOME; TRENDS;

AGED; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; ST ELEVATION MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TIME-TO-TREATMENT;

EID: 84994468997     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.004113     Document Type: Article

References (27)

1. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362-e425.
2. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA guidelines for the management of patients with STelevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation. 2004;110:588-636.
3. Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, Ho PM, Kosiborod MN, Masoudi FA, Nallamothu BK; American College of Cardiology/American Heart Association Task Force on Performance Measures, American Academy of Family Physicians, American College of Emergency Physicians, American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (writing committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction) developed in collaboration with the American Academy of Family Physicians and American College of Emergency Physicians endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. J Am Coll Cardiol. 2008;52:2046-2099.
4. Vora AN, Holmes DN, Rokos I, Roe MT, Granger CB, French WJ, Antman E, Henry TD, Thomas L, Bates ER, Wang TY. Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry. JAMA Intern Med. 2015;175:207-215.
5. Schiele F, Hochadel M, Tubaro M, Meneveau N, Wojakowski W, Gierlotka M, Polonski L, Bassand JP, Fox KA, Gitt AK. Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in STelevation myocardial infarction. Eur Heart J. 2010;31:2614-2624.
6. Xian Y, Pan W, Peterson ED, Heidenreich PA, Cannon CP, Hernandez AF, Friedman B, Holloway RG, Fonarow GC; GWTG Steering Committee and Hospitals. Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTGCAD hospitals. Am Heart J. 2010;159:207-214.
7. Cohen MG, Fonarow GC, Peterson ED, Moscucci M, Dai D, Hernandez AF, Bonow RO, Smith SC Jr. Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation. 2010;121:2294-2301.
8. LaBresh KA, Ellrodt AG, Gliklich R, Liljestrand J, Peto R. Get With the Guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med. 2004;164:203-209.
9. LaBresh KA, Fonarow GC, Smith SC Jr, Bonow RO, Smaha LC, Tyler PA, Hong Y, Albright D, Ellrodt AG; Get With The Guidelines Steering Committee. Improved treatment of hospitalized coronary artery disease patients with the Get With the Guidelines program. Crit Pathw Cardiol. 2007;6:98-105.
10. LaBresh KA, Gliklich R, Liljestrand J, Peto R, Ellrodt AG. Using "get with the guidelines" to improve cardiovascular secondary prevention. Jt Comm J Qual Saf. 2003;29:539-550.
11. Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL; Get With The Guidelines Steering Committee, Investigators. Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With the Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes. 2012;5:126-133.
12. Ambardekar AV, Fonarow GC, Dai D, Peterson ED, Hernandez AF, Cannon CP, Krantz MJ; Get With The Guidelines Steering Committee, Hospitals. Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease program). Am J Cardiol. 2010;105:139-143.
13. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
14. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003;92:824-826.
15. Concannon TW, Nelson J, Goetz J, Griffith JL. A percutaneous coronary intervention lab in every hospital? Circ Cardiovasc Qual Outcomes. 2012;5: 14-20.
16. Jacobs AK, Antman EM, Faxon DP, Gregory T, Solis P. Development of systems of care for ST-elevation myocardial infarction patients: executive summary. Circulation. 2007;116:217-230.
17. Wang TY, Peterson ED, Ou FS, Nallamothu BK, Rumsfeld JS, Roe MT. Door-toballoon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. Am Heart J. 2011;161:76-83.e71.
18. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE 3rd, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A Jr, Gregoratos G, Ryan TJ, Smith SC Jr. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on management of acute myocardial infarction). J Am Coll Cardiol. 1999;34:890-911.
19. Menees DS, Peterson ED, Wang Y, Curtis JP, Messenger JC, Rumsfeld JS, Gurm HS. Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med. 2013;369:901-909.
20. Jneid H. Interplay between time of presentation, timeliness of reperfusion, and outcome after ST-segment-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2014;7:637-639.
21. Kumbhani DJ, Cannon CP, Fonarow GC, Liang L, Askari AT, Peacock WF, Peterson ED, Bhatt DL; Get With the Guidelines Steering Committee Investigators. Association of hospital primary angioplasty volume in STsegment elevation myocardial infarction with quality and outcomes. JAMA. 2009;302:2207-2213.
22. Gibson CM, Pride YB, Frederick PD, Pollack CV Jr, Canto JG, Tiefenbrunn AJ, Weaver WD, Lambrew CT, French WJ, Peterson ED, Rogers WJ. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and inhospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008;156:1035-1044.
23. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, Lazzam C, Schwartz B, Casanova A, Goodman SG; TRANSFER-AMI Trial Investigators. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360:2705-2718.
24. Claeys MJ, de Meester A, Convens C, Dubois P, Boland J, De Raedt H, Vranckx P, Coussement P, Gevaert S, Sinnaeve P, Evrard P, Beauloye C, Renard M, Vrints C. Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction. Arch Intern Med. 2011;171:544-549.
25. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F; STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368:1379-1387.
26. Bhatt DL. Timely PCI for STEMI-still the treatment of choice. N Engl J Med. 2013;368:1446-1447.
27. QualityNet Specifications Manual, Version 4.4a. Available at: http://www. qualitynet.org/dcs/ContentServer?c=Page&pagename=QnetPublic%2FPage% 2FQnetTier4&cid=1228773989482. Accessed January 18, 2016.